Wikidata

(Q64719863)

English

Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy

clinical trial

In more languages

Statements

title
An Open-Label, Multi-Center, Expanded Access Study of RAD001 in Patients With Metastatic Carcinoma of the Kidney Who Are Intolerant of or Have Progressed Despite Any AvailableVascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy (English)
0 references
sponsor
Novartis
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
Czech Republic
0 references
Germany
0 references
Hungary
0 references
Lebanon
0 references
Norway
0 references
Switzerland
0 references
Turkey
0 references
United Kingdom
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64719863&oldid=2141524956"